Posachedwapa, JYMed Technology Co., Ltd. yalengeza kuti Leuprorelin Acetate, yopangidwa ndi kampani yake ya Hubei JX Bio-Pharmaceutical Co., Ltd., yadutsa bwino kuyendera kalembera wa mankhwala.
Chidule cha Msika Woyamba wa Mankhwala
Leuprorelin Acetate ndi mankhwala obaya omwe amagwiritsidwa ntchito pochiza matenda omwe amadalira mahomoni, omwe ali ndi formula ya C59H84N16O12•xC2H4O2. Ndi gonadotropin-release hormone agonist (GnRHa) yomwe imagwira ntchito poletsa dongosolo la pituitary-gonadal. Poyambirira adapangidwa ndi AbbVie ndi Takeda Pharmaceutical, mankhwalawa amagulitsidwa pansi pa mayina osiyanasiyana m'maiko osiyanasiyana. Ku United States, imagulitsidwa pansi pa dzina la LUPRON DEPOT, pomwe ku China, imagulitsidwa ngati Yina Tong.
Njira Yomveka ndi Maudindo Ofotokozedwa Bwino
Kuyambira 2019 mpaka 2022, kafukufuku wamankhwala ndi chitukuko zidamalizidwa, kutsatiridwa ndi kulembetsa kwa API mu Marichi 2024, pomwe chidziwitso chovomerezeka chidalandiridwa. Kuyang'anira kalembera wa mankhwala kudachitika mu Ogasiti 2024. JYMed Technology Co., Ltd. inali ndi udindo wokonza njira, kukonza njira zowunikira, maphunziro odetsedwa, kutsimikizira kapangidwe kake, ndi kutsimikizira njira. Hubei JX Bio-Pharmaceutical Co., Ltd. anali kuyang'anira ntchito yovomerezeka, kutsimikizira njira zowunikira, ndi maphunziro okhazikika a API.
Kukulitsa Msika ndi Kufuna Kukula
Kuchulukirachulukira kwa khansa ya prostate ndi uterine fibroids kukuyendetsa kufunikira kwa Leuprorelin Acetate. Msika waku North America pano ukulamulira msika wa Leuprorelin Acetate, ndikukula kwa ndalama zothandizira zaumoyo komanso kuvomereza matekinoloje atsopano kukhala oyendetsa kukula. Nthawi yomweyo, msika waku Asia, makamaka China, ukuwonetsanso kufunikira kwakukulu kwa Leuprorelin Acetate. Chifukwa chakuchita bwino, kufunikira kwa mankhwalawa padziko lonse lapansi kukukulirakulira, kukula kwa msika kukuyembekezeka kufika $3,946.1 miliyoni pofika 2031, kuwonetsa kuchuluka kwapachaka (CAGR) kwa 4.86% kuyambira 2021 mpaka 2031.
Za JYMed
Shenzhen JYMed Technology Co., Ltd. (yomwe tsopano imatchedwa JYMed) idakhazikitsidwa mu 2009, ikuchita kafukufuku, chitukuko, kupanga, ndi malonda a peptides ndi zinthu zokhudzana ndi peptide. Ndi malo amodzi ofufuzira komanso maziko atatu opangira, JYMed ndi amodzi mwa omwe amapanga ma API a peptide opangidwa ndi mankhwala ku China. Gulu lalikulu la R&D la kampaniyo limadzitamandira kwazaka zopitilira 20 pantchito ya peptide ndipo ladutsa bwino pakuwunika kwa FDA kawiri. Dongosolo lambiri komanso logwira mtima la ma peptide la JYMed limapatsa makasitomala ntchito zambiri, kuphatikiza kupanga ndi kupanga ma peptides achire, ma peptides anyama, antimicrobial peptides, ndi cosmetic peptides, komanso kulembetsa ndi kuthandizira pakuwongolera.
Zochita Zazikulu Zamalonda
1.Kulembetsa kwapakhomo komanso kumayiko ena kwa ma peptide API
2.Veterinary and cosmetic peptides
3.Custom peptides ndi CRO, CMO, OEM misonkhano
4.PDC mankhwala (peptide-radionuclide, peptide-yaing'ono molekyulu, peptide-mapuloteni, peptide-RNA)
Kuphatikiza pa Leuprorelin Acetate, JYMed yatumiza zolemba zolembetsa ndi FDA ndi CDE pazinthu zina zingapo za API, kuphatikiza mankhwala otchuka omwe pano a GLP-1RA monga Semaglutide, Liraglutide ndi Tirzepatide. Makasitomala amtsogolo omwe akugwiritsa ntchito zinthu za JYMed azitha kulozera mwachindunji nambala yolembetsa ya CDE kapena nambala ya fayilo ya DMF potumiza mafomu olembetsa ku FDA kapena CDE. Izi zidzachepetsa kwambiri nthawi yofunikira pokonzekera zikalata zofunsira, komanso nthawi yowunikira komanso mtengo wowunikiranso zinthu.
Lumikizanani nafe
Malingaliro a kampani Shenzhen JYMed Technology Co., Ltd.
Adilesi:8th & 9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Foni:+ 86 755-26612112
Webusaiti:http://www.jymedtech.com/
Nthawi yotumiza: Aug-29-2024